{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:18Z","timestamp":1793750238982,"version":"4.6.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.seminhematol.2023.08.002","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T11:17:22Z","timestamp":1692875842000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa"],"prefix":"10.1053","volume":"60","author":[{"given":"Mwashungi","family":"Ally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Balandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2023.08.002_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijns5020020","article-title":"Sickle cell disease\u2014genetics, pathophysiology, clinical presentation, and treatment","volume":"5","author":"Inusa","year":"2019","journal-title":"Int J Neonat Screen"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0002","first-page":"4","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of Sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0004","doi-asserted-by":"crossref","first-page":"e28620","DOI":"10.1002\/pbc.28620","article-title":"Extremely high birth prevalence of sickle cell disease in rural Tanzania","volume":"67","author":"Eastburg","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/inthealth\/ihz028","article-title":"Newborn screening for sickle cell disease: An innovative pilot program to improve child survival in Dares Salaam, Tanzania","volume":"11","author":"Nkya","year":"2019","journal-title":"Int Health"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26735","article-title":"High birth prevalence of sickle cell disease in Northwestern","volume":"65","author":"Ambrose","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0007","doi-asserted-by":"crossref","first-page":"e14699","DOI":"10.1371\/journal.pone.0014699","article-title":"Mortality in sickle cell anemia in africa: a prospective cohort study in Tanzania","volume":"6","author":"Makani","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0008","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0009","first-page":"1","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/193252","article-title":"Sickle cell disease: new opportunities and challenges in Africa","author":"Makani","year":"2013","journal-title":"Sci World J"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/jammr\/2019\/v30i830220","article-title":"Sickle cell disease in East African countries: prevalence, complications and management","volume":"30","author":"Kawuki","year":"2019","journal-title":"J Adv Med Med Res"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0012","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000441-194804000-00008","article-title":"The significance of the paucity of sickle cells in newborn Negro infants","volume":"215","author":"Waston","year":"1948","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0013","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0014","unstructured":"World Health Organization (2010) Birth defects, https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA63\/A63_R17-en.pdf (accessed 8 May 2023)."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0015","unstructured":"WHO Regional Committee for Africa, https:\/\/apps.who.int\/iris\/handle\/10665\/19792 (2011, accessed 8 May 2023)."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0016","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ajh.23578","article-title":"A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola","volume":"88","author":"Mcgann","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.29068","article-title":"Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: results and lessons learned","volume":"68","author":"Segbefia","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0018","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12687-020-00463-7","article-title":"Empowering newborn screening programs in African countries through establishment of an international collaborative effort","volume":"11","author":"Therrell","year":"2020","journal-title":"J Community Genet"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jcp.2008.058958","article-title":"Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns","volume":"62","author":"Tshilolo","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0020","unstructured":"Improving healthcare and social services for those with sickle cell disease, https:\/\/www.fondationpierrefabre.org\/en\/our-programmes\/combatting-sickle-cell-disease\/improving-healthcare-social-services-sickle-cell-disease\/ (accessed 13 May 2023)."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0015593","article-title":"A large cross-sectional community-based study of newborn care practices in Southern Tanzania","volume":"5","author":"Penfold","year":"2010","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vaccine.2021.11.005","article-title":"Child vaccination in sub-Saharan Africa\u202f: increasing coverage addresses inequalities","volume":"40","author":"Tekle","year":"2022","journal-title":"Vaccine"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0023","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2352-3026(20)30143-5","article-title":"Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study","volume":"7","author":"Nnodu","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2017.28.209.10466","article-title":"Improving the efficiency and standards of a national immunization program review\u202f: lessons learnt from United Republic of Tanzania","volume":"28","author":"Lyimo","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0025","first-page":"1","article-title":"Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania","volume":"22","author":"Christopher","year":"2021","journal-title":"Bmc Genomics [Electronic Resource]"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0026","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/ijlh.13929","article-title":"Potential of point of care tests for newborn screening for sickle cell disease:evaluation of HemotypeSCTM and sickle SCAN\u00ae in Tanzania","volume":"44","author":"Christopher","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.24398","article-title":"DNA testing for sickle cell anemia in Africa: implementation choices for the Democratic Republic of Congo","volume":"36","author":"Ngole","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0028","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1182\/bloodadvances.2022007698","article-title":"The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology","volume":"6","author":"Green","year":"2022","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v10i1.1303","article-title":"Operational analysis of the national sickle cell screening programme in the Republic of Uganda","volume":"10","author":"Hernandez","year":"2021","journal-title":"Afr J Lab Med"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0030","doi-asserted-by":"crossref","first-page":"p304","DOI":"10.1186\/s12913-016-1572-6","article-title":"Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis","author":"Kuznik","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0031","first-page":"e2354","article-title":"A multi-centre survey of acceptability of newborn screening for sickle cell disease in Nigeria","author":"Nnodu","year":"2018","journal-title":"Cureus"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0032","first-page":"1","article-title":"Outcomes of the effect of premarital counseling for sickle cell disease and \u03b2-Thalassemia on marital decisions in the Kingdom of Bahrain","volume":"2","author":"Bubshait","year":"2021","journal-title":"Int J Fam Med Prim Care"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0033","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2321-4848.183342","article-title":"Sickle cell disease genetic counseling and testing: a review","volume":"4","author":"Aneke","year":"2016","journal-title":"Arch Med Heal Sci"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0034","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12687-021-00539-y","article-title":"Premarital genetic screening and care of Tanzanian children with sickle cell disease: a qualitative study on parents\u2019 views and experiences","volume":"12","author":"Kisanga","year":"2021","journal-title":"J Community Genet"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0035","unstructured":"Tanzania: government calls for raising awareness on sickle cell disease, https:\/\/allafrica.com\/stories\/202112140067.html (2021, accessed 8 May 2023)."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-022-14859-2","article-title":"The efficacy of maternal health education and maternal screening on knowledge and the uptake of infant screening for sickle cell disease in Dar-Es-Salaam, Tanzania; a quasi experimental study","volume":"23","author":"Tutuba","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0037","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood-2019-127945","article-title":"Non-invasive prenatal diagnosis (NIPD) of sickle-cell disease by massively parallel sequencing of cell-free fetal DNA in maternal serum","volume":"134","author":"Daniel","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0038","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bjh.16529","article-title":"A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies","volume":"190","author":"van Campen","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0039","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1182\/blood.2019002099","article-title":"A method for non-invasive prenatal diagnosis of monogenic autosomal recessive disorders. a method for non-invasive prenatal diagnosis of monogenic autosomal recessive disorders","volume":"134","author":"Cutts","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000431020","article-title":"Perspectives in genetics and sickle cell disease prevention in Africa:aeroon","volume":"18","author":"Wonkam","year":"2015","journal-title":"Public Health Genomics"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0041","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bjh.14594","article-title":"Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004\u20132016","author":"Tluway","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0042","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2352-3026(22)00004-7","article-title":"Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study","volume":"9","author":"Ranque","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0043","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/tmi.12428","article-title":"Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality","volume":"20","author":"Makani","year":"2015","journal-title":"Trop Med Int Heal"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.hemonc.2019.12.007","article-title":"Standard management of sickle cell disease complications","volume":"13","author":"Abboud","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0045","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.08.002_bib0046","article-title":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease","volume":"8","author":"Rankine-Mullings","year":"2021","journal-title":"Cochr DatabaseSyst Reviews"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01781-w","article-title":"Hydroxyurea and blood transfusion therapy for sickle cell disease in South Asia: inconsistent treatment of a neglected disease","volume":"16","author":"Darshana","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0048","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.21865","article-title":"ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children","volume":"86","author":"De Montalembert","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0049","article-title":"The WHO pain ladder: do we need another step?","volume":"14","author":"Pergolizzi","year":"2014"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2022.1052179","article-title":"Development of multi-level standards of care recommendations for sickle cell disease: experience from SickleInAfrica","volume":"13","author":"Paintsil","year":"2023","journal-title":"Front Genet"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0051","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.hoc.2018.01.014","article-title":"Key components of pain management for children and adults with sickle cell disease","volume":"32","author":"Brandow","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0052","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/17474086.2019.1627192","article-title":"Considering the spleen in sickle cell disease","author":"El Hoss","year":"2019","journal-title":"Expert Review of Hematology"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0053","first-page":"S31","article-title":"Streptococcus pneumoniae infection in sickle cell disease patients","author":"Navalkele","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0054","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/03630269.2021.1954943","article-title":"Utilization of pneumococcal vaccine and penicillin prophylaxis in sickle cell disease in three African countries: assessment among healthcare providers in SickleInAfrica","volume":"45","author":"Brown","year":"2021","journal-title":"Hemoglobin"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-08895-6","article-title":"Determinants of misuse of antibiotics among parents of children attending clinics in regional referral hospitals in Tanzania","volume":"12","author":"Mutagonda","year":"2022","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0056","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijid.2019.01.035","article-title":"Carriage of penicillin-non-susceptible pneumococci among children in northern Tanzania in the 13-valent pneumococcal vaccine era","volume":"81","author":"Emg\u00e5rd","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0057","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1099\/jmm.0.042598-0","article-title":"Penicillin resistance and serotype distribution of Streptococcus pneumoniae in nasopharyngeal carrier children under 5 years of age in Dar es Salaam, Tanzania","volume":"61","author":"Moyo","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-022-07902-5","article-title":"Pneumococcal concentration and serotype distribution in preschool children with radiologically confirmed pneumonia compared to healthy controls prior to introduction of pneumococcal vaccination in Zanzibar: an observational study","volume":"22","author":"Elfving","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0059","first-page":"743","article-title":"Risk of invasive pneumococcal disease in children with sickle cell disease in England: a national observational cohort study, 2010-2015","author":"Oligbu","year":"2019","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0060","doi-asserted-by":"crossref","unstructured":"Oligbu G, Fallaha M, Pay L, et al. Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature. Br J Haematol; 185.","DOI":"10.1111\/bjh.15846"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0061","first-page":"27","article-title":"A Review of Pneumococcal Vaccines\u202f: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0062","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/MPH.0000000000000510","article-title":"Assessing the immunogenic response of a single center's pneumococcal vaccination protocol in sickle cell disease","volume":"38","author":"Santoro","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0063","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood.V108.11.3802.3802","article-title":"Sickle cell anaemia in East Africa: preliminary results from a cohort study","author":"Makani","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3556-0","article-title":"Safety and effectiveness of antimalarial therapy in sickle cell disease: A systematic review and network meta-analysis","volume":"18","author":"Frimpong","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa","volume":"380","author":"Tshilolo","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0066","doi-asserted-by":"crossref","first-page":"e27365","DOI":"10.1002\/pbc.27365","article-title":"Intermittent or uneven daily administration of low-dose hydroxyurea is effective in treating children with sickle cell anemia in Angola","author":"Chambers","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0067","doi-asserted-by":"crossref","first-page":"e28969","DOI":"10.1002\/pbc.28969","article-title":"Hydroxyurea in children with sickle cell disease in a resource-poor setting: monitoring and effects of therapy. a practical perspective","author":"Nnebe-Agumadu","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0068","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4314\/ahs.v21i2.36","article-title":"Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in jos, north-central Nigeria","author":"Ofakunrin","year":"2021","journal-title":"Afr Health Sci"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0069","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/JBM.S380901","article-title":"Outcomes of hydroxyurea accessed via various means and barriers affecting its usage among children with sickle cell anaemia in North-Western Tanzania","author":"Ambrose","year":"2023","journal-title":"Journal of Blood Medicine"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/frhem.2023.1040720","article-title":"Development of the sickle Pan-African research consortium registry in Tanzania\u202f: opportunity to harness data science for sickle cell disease","volume":"2","author":"Kandonga","year":"2023","journal-title":"Front Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0071","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/16078454.2021.1880752","article-title":"Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo","volume":"26","author":"Kambale-kombi","year":"2021","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0072","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ajh.25034","article-title":"Realizing effectiveness across continents with hydroxyurea: enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa","volume":"93","author":"McGann","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0073","first-page":"213","article-title":"Health care disparities among adolescents and adults with sickle cell disease: a community-based needs assessment to inform intervention strategies","volume":"27","author":"Treadwell","year":"2020","journal-title":"J Community Med Health Educ"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2021.765958","article-title":"Barriers to therapeutic use of hydroxyurea for sickle cell disease in Nigeria: a cross-sectional survey","volume":"12","author":"Okocha","year":"2022","journal-title":"Front Genet"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/hemato2040048","article-title":"Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania","volume":"2","author":"Kilonzi","year":"2021","journal-title":"Hemato"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0076","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2018-160","article-title":"Greater Barriers to Hydroxyurea (HU) Associated with Poorer Health Related Quality of Life (HRQL) in Youth with Sickle Cell Disease","volume":"132","author":"Smaldone","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0077","first-page":"E2","article-title":"Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost","author":"Costa","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0078","article-title":"Folate supplementation in people with sickle cell disease","volume":"3","author":"Dixit","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnut.2021.642306","article-title":"Detectable unmetabolized folic acid and elevated folate concentrations in folic acid-supplemented canadian children with sickle cell disease","volume":"8","author":"Williams","year":"2021","journal-title":"Front Nutr"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4314\/mmj.v34i2.9","article-title":"Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study","volume":"34","author":"Nnajekwu","year":"2022","journal-title":"Malawi Med J"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0081","unstructured":"WHO Afro: nutrition, https:\/\/www.afro.who.int\/health-topics\/nutrition (2017, accessed 9 May 2023)."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0082","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1016\/S2352-3026(21)00209-X","article-title":"Safe blood supply in sub-Saharan Africa: challenges and opportunities","volume":"8","author":"Dei-Adomakoh","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0083","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1778-428X.2004.tb00108.x","article-title":"Blood transfusion in Sub-Saharan Africa","volume":"6","author":"Allain","year":"2004","journal-title":"Transfusion Alternatives in Transfusion Medicine"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0084","first-page":"1","article-title":"Limited exchange transfusion can be very beneficial in sickle cell anemia with acute chest syndrome: a case report from Tanzania","volume":"2018","author":"Chamba","year":"2018","journal-title":"Case Rep Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0085","first-page":"306","article-title":"Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso","volume":"33","author":"Sawadogo","year":"2023","journal-title":"Br Blood Transfus Soc."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0086","unstructured":"Meda E, Magesa PM, Marlow T, et al. Europe PMC funders group red blood cell alloimmunization in sickle cell disease patients in Tanzania. 2017; 11: 775\u201380."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0087","doi-asserted-by":"crossref","unstructured":"Centre M, Sciences A, Africa I. Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania. Afr J Lab Med 2020; 9: 1\u20135.","DOI":"10.4102\/ajlm.v9i1.823"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0088","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-015-0050-3","article-title":"Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria","volume":"3","author":"Kangiwa","year":"2015","journal-title":"Biomark Res"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0089","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/trf.15197","article-title":"Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease","volume":"59","author":"Boateng","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.HS9.0000873036.01916.17","article-title":"P-035: red blood cell alloimmunization in sickle cell disease patients in the Democratic Republic of Congo","volume":"6","author":"Kambale-Kombi","year":"2022","journal-title":"Hemasphere"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0091","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2019.12.008","article-title":"Cerebral infarcts and vasculopathy in Tanzanian children with sickle cell anemia","volume":"107","author":"Jacob","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0092","first-page":"1058","article-title":"Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting","volume":"94","author":"Ohaeri","year":"2002","journal-title":"J Natl Med Assoc"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0093","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1177\/10497323211006384","article-title":"It is not easy\u201d: cultural influences of sickle cell disease management in rural, Eastern Sierra Leone","volume":"31","author":"Ibemere","year":"2021","journal-title":"Qual Health Res"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0094","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/10245332.2018.1457200","article-title":"Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease","volume":"23","author":"Cronin","year":"2018","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03630269.2014.896810","article-title":"Challenge of managing sickle cell disease in a pediatric population living in Kinshasa, Democratic Republic of Congo: a sickle cell center experience","volume":"38","author":"Aloni","year":"2014","journal-title":"Hemoglobin"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2021.773207","article-title":"Healthcare workers\u2019 knowledge and resource availability for care of sickle cell disease in Dar Es Salaam, Tanzania","volume":"12","author":"Jonathan","year":"2022","journal-title":"Front Genet"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0097","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/03630269.2019.1649278","article-title":"Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria","volume":"43","author":"Adeyemo","year":"2019","journal-title":"Hemoglobin"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0098","unstructured":"Mbiya BM, Disashi GT, Gulbis B. Sickle cell disease in the Democratic Republic of Congo: assessing physicians \u2019 knowledge and practices. 2020; 1\u201310."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0099","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9653092","article-title":"Effect of health education programme on the knowledge of and attitude about sickle cell anaemia among male secondary school students in the Jazan Region of Saudi Arabia: health policy implications","author":"Kotb","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/smj.smj_9_20","article-title":"Effect of health education on knowledge and awareness of sickle cell disease among adolescents","author":"Ezenwosu","year":"2021","journal-title":"Sahel Med J"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0101","first-page":"163","article-title":"Effects of health education on knowledge and attitude of youth corps members to sickle cell disease and its screening in Lagos State","volume":"2","author":"Olatona","year":"2012","journal-title":"J Community Med Health Educ"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.htct.2018.06.004","article-title":"Knowledge of professional healthcare providers about sickle cell disease: impact of a distance education course","author":"Diniz","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0103","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S2352-3026(20)30006-5","article-title":"SickleInAfrica","volume":"7","author":"Makani","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0104","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S2213-8587(23)00118-3","article-title":"The PEN-Plus Partnership: addressing severe chronic non-communicable diseases among the poorest billion","volume":"11","author":"Bukhman","year":"2023","journal-title":"LAncet Diabetes Endocrinol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0105","unstructured":"Serjeant G. Jamaica, the Caribbean and sickle cell Disease."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0106","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.bbmt.2009.10.001","article-title":"Severe sickle cell disease-pathophysiology and therapy","author":"Buchanan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0107","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jcyt.2018.04.003","article-title":"Gene therapy for sickle cell disease: an update","volume":"20","author":"Demirci","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2015-09-618587","article-title":"Genetic treatment of a molecular disorder\u202f: gene therapy approaches to sickle cell disease","volume":"127","author":"Hoban","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0109","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood.2019003776","article-title":"Gene therapy for sickle cell disease: moving from the bench to the bedside","volume":"138","author":"Allistair","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2022.12.001","article-title":"Gene editing for sickle cell disease and transfusion dependent thalassemias-A cure within reach","volume":"60","author":"Eckrich","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0111","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2020.09.001","article-title":"In Vivo HSC Gene Therapy Using a Bi-modular HDAd5\/35++ Vector Cures Sickle Cell Disease in a Mouse Model","volume":"29","author":"Li","year":"2020","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0112","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-med-042921-021707","article-title":"Diverse Approaches to Gene Therapy of Sickle Cell Disease","volume":"74","author":"White","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.770640","article-title":"Treating Rare Diseases in Africa: The Drugs Exist but the Need Is Unmet","volume":"12","author":"Luzzatto","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0114","unstructured":"NIH launches new collaboration to develop gene-based cures for sickle cell disease and HIV on global scale, https:\/\/www.nih.gov\/news-events\/news-releases\/nih-launches-new-collaboration-develop-gene-based-cures-sickle-cell-disease-hiv-global-scale (2019)."},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0115","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.ymthe.2021.05.024","article-title":"Collaborative science to advance gene therapies in resource-limited parts of the world","volume":"29","author":"McCune","year":"2021","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0116","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049765","article-title":"The future of sickle cell disease therapeautics rests in genomics","author":"Wonkam","year":"2023","journal-title":"Dis Model Mech"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0117","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/d41586-021-02139-9","article-title":"Collect more data from Africa to improve gene therapy","volume":"596","author":"Wonkam","year":"2021","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0118","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13023-022-02391-w","article-title":"Increasing African genomic data generation and sharing to resolve rare and undiagnosed diseases in Africa: a call-to-action by the H3Africa rare disease working group","author":"Lumaka","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0119","first-page":"59","article-title":"H3Africa\u202f: current perspectives","author":"Matimba","year":"2018","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0120","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41591-022-02033-5","article-title":"Africa must participate in finding a gene therapy cure for sickle cell disease","volume":"28","author":"Moshi","year":"2022","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0121","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0300-1652.160355","article-title":"Haematopoietic stem cell transplantation in Nigerian sickle cell anaemia children patients","volume":"56","author":"Isgro","year":"2015","journal-title":"Niger Med J"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0122","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7062630","article-title":"Awareness, Knowledge, and Acceptance of Haematopoietic Stem Cell Transplantation for Sickle Cell Anaemia in Nigeria","author":"Adediran","year":"2016","journal-title":"Bone Marrow Res"},{"key":"10.1053\/j.seminhematol.2023.08.002_bib0123","unstructured":"Milestone in bone marrow transplant. Daily News, https:\/\/dailynews.co.tz\/milestone-in-bone-marrow-transplant\/(accessed 13 May 2023)."}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:29:31Z","timestamp":1758522571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0037196323000598"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.08.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}